About the Company
We do not have any company description for Alector, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Alector, Inc.
Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call
Call Scheduled for Thursday, August 7, 2025, at 4:30 p.m. ET/1:30 p.m. PTSOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical ...
Alector, Inc. Reports Q4 2024 Financial Results and Provides ... - Nasdaq
Alector, Inc. reported its fourth quarter and full year 2024 financial results, highlighting significant clinical developments in neurodegenerative disease therapies.
Earnings Update: Alector, Inc. (NASDAQ:ALEC) Just Reported And Analysts Are Boosting Their Estimates
Alector, Inc. (NASDAQ:ALEC) investors will be delighted, with the company turning in some strong numbers with its latest results. The results were impressive, with revenues of US$7.9m exceeding ...
Alector Inc. (ALEC) Stock Price Today - WSJ
View the latest Alector Inc. (ALEC) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Alector, Inc. (ALEC) Q2 2024 Earnings Call Transcript
Alector, Inc. (NASDAQ: ALEC) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Katie Hogan – Senior Director-Corporate Communications and Investor Relations Arnon ...
Alector: Milestone Uncertainty Plus Lack Of Product Revenue
This is my first look at Alector, Inc. (NASDAQ: ALEC) an intriguing clinical stage biotech. Like hundreds of its peers it has no product income, with none in sight for the next few years. What it ...
Broker Revenue Forecasts For Alector, Inc. (NASDAQ:ALEC) Are Surging ...
Following the upgrade, the current consensus from Alector's seven analysts is for revenues of US$36m in 2021 which - if met - would reflect a major 100% increase on its sales over the past 12 ...
Alector, Inc. (NASDAQ:ALEC) Shares Purchased by XTX Topco Ltd
Alector Trading Down 2.6 % Alector stock opened at $1.13 on Wednesday. Alector, Inc. has a 12 month low of $0.87 and a 12 month high of $6.78. The stock’s 50 day simple moving average is $1.27 ...
Alector: Q1 Earnings Snapshot - WTOP News
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Alector Inc. (ALEC) on Wednesday reported a loss of $36.1 million in its first quarter.
GSK, Alector to develop Parkinson's, Alzheimer's drugs in $2.2 bln deal
GlaxoSmithKline Plc (GSK.L) and U.S. firm Alector Inc (ALEC.O) will together develop antibody-based treatments for Parkinson's, Alzheimer's and other similar diseases in a deal worth up to $2.2 ...
Alector Inc. Advanced Charts | ALEC | Barron's
Alector Inc. advanced stock charts by Barron's. View ALEC historical stock data and compare to other stocks, and exchanges.
Why Did Analysts Give Alector, Inc. (ALEC) a Moderate Buy Rating?
Alector, Inc. (NASDAQ:ALEC) holds a Moderate Buy rating based on analysis by 7 Wall Street analysts over the past 3 months. The average 12-month price target is $15.17, ranging from $9.00 to $35.00.
Similar Companies
Loading the latest forecasts...